Investigative Medicine Division
We aim to rapidly translate innovative science into patient benefit across a range of disease areas. From molecular biology and target discovery, through to interventional medicine and informing policy, we bring together researchers in a diverse range of specialties including acute stroke, dementia and immunology.
Lymphatic vessels in bone support regeneration after injury.
Biswas L. et al, (2023), Cell, 186, 382 - 397.e24
Structural basis for a conserved neutralization epitope on the receptor-binding domain of SARS-CoV-2.
Huang K-YA. et al, (2023), Nat Commun, 14
Intelectin-1 binds and alters the localization of the mucus barrier-modifying bacterium Akkermansia muciniphila.
Matute JD. et al, (2023), J Exp Med, 220
Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication.
Moll T. et al, (2023), Life Sci Alliance, 6
Staphylococcal phosphatidylglycerol antigens activate human T cells via CD1a.
Monnot GC. et al, (2022), Nat Immunol
6 July 2022
Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.
Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease
1 December 2021
Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.
19 January 2023
Bones were thought to lack lymphatic vessels, but new research from the Kusumbe Group published in Cell not only locates them within bone tissue, but demonstrates their role in bone and blood cell regeneration and reveals changes associated with aging.
29 September 2022
The Royal Microscopical Society awards celebrate the best in microscopy, recognising those making a special contribution to microscopy, cytometry and imaging.